Sign in

CIK 0001703647

  • Non-accelerated filer
  • Smaller reporting company

Korro Bio, Inc.

Sign in to watch
Ticker
KRRO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
472324450
Phone
+1 617-468-1999
Business address
60 FIRST STREET, 2ND FLOOR, SUITE 250, CAMBRIDGE, MA, 02141
Former names
Frequency Therapeutics, Inc.
Open-market buys, last 90 days
$884,752
in 1 filing
Open-market sales, last 90 days
$1,763,410
in 5 filings, $1.8M under 10b5-1 plans

Net −$878,658. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2023-07-17 Lucchino David L. President and CEO Sale 10b5-1 −2,775 $0.68 $2K 702,807
2023-07-17 Loose Christopher R. Chief Scientific Officer Sale 10b5-1 −1,415 $0.67 $948 196,037
2023-07-14 Loose Christopher R. Chief Scientific Officer Sale 10b5-1 −906 $0.59 $535 197,452
2023-07-14 Lucchino David L. President and CEO Sale 10b5-1 −1,815 $0.59 $1K 705,582
2023-07-14 Mitrano Richard J. VP Finance & Operations Sale 10b5-1 −148 $0.60 $89 54,508
2023-07-13 Loose Christopher R. Chief Scientific Officer Sale 10b5-1 −1,329 $0.39 $518 198,358
2023-07-13 Lucchino David L. President and CEO Sale 10b5-1 −2,646 $0.39 $1K 707,397
2023-07-13 Mitrano Richard J. VP Finance & Operations Sale 10b5-1 −227 $0.39 $89 54,656
2023-07-12 Loose Christopher R. Chief Scientific Officer Sale 10b5-1 −1,335 $0.39 $521 199,687
2023-07-12 Lucchino David L. President and CEO Sale 10b5-1 −2,649 $0.39 $1K 710,043
2023-07-12 Mitrano Richard J. VP Finance & Operations Sale 10b5-1 −220 $0.40 $88 54,883
2023-07-11 Loose Christopher R. Chief Scientific Officer Sale 10b5-1 −1,363 $0.37 $504 201,022
2023-07-11 Lucchino David L. President and CEO Sale 10b5-1 −2,731 $0.37 $1K 712,692
2023-07-11 Mitrano Richard J. VP Finance & Operations Sale 10b5-1 −228 $0.37 $84 55,103
2023-07-10 Mitrano Richard J. VP Finance & Operations Sale 10b5-1 −220 $0.37 $81 55,331
2023-07-10 Lucchino David L. President and CEO Sale 10b5-1 −2,591 $0.38 $985 715,423
2023-07-10 Loose Christopher R. Chief Scientific Officer Sale 10b5-1 −1,304 $0.37 $482 202,385
2023-07-10 Loose Christopher R. Chief Scientific Officer Sale 10b5-1 −1,304 $0.37 $482 66,023
2023-07-10 Loose Christopher R. Chief Scientific Officer Option exercise 10b5-1 +4,546 70,569
2023-07-10 Loose Christopher R. Chief Scientific Officer Option exercise · Restricted Stock Unit 10b5-1 −4,546 131,816

Page 13 of 23 · 441 trades